Business

Drug Companies Cope with Declines, May Merge

  • Playlist
  • Download
  • Embed
    <iframe src="http://www.npr.org/player/embed/1869210/1869211" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The recent merger of drug giants Aventis and Sanofi may only be the beginning of a new wave of consolidation in the drug industry, say observers. Companies are combining in an effort to cut costs — a move that analysts say reflects a lack of new drugs. NPR's Snigdha Prakash reports.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

NPR thanks our sponsors

Become an NPR sponsor

Support comes from